Skip to search.
 FTSE 100 Up 0.31%

Alkermes plc (ALKS)

-NasdaqGS
44.47 Down 0.03(0.07%) 29 Aug 21:00
Prev Close:44.50
Open:44.65
Bid:42.50 x 100
Ask:47.00 x 3500
1y Target Est:50.82
Beta:2.01629
Earnings Date:27 Oct - 31 Oct (Est.)
Day's Range:43.75 - 44.90
52wk Range:27.14 - 80.71
Volume:408,692
Avg Vol (3m):863,988
Market Cap:6.74b
P/E (ttm):N/A
EPS (ttm):-1.83
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSDown 0.07%6.74b
LLYUp 0.46%82.94b
GSKUp 0.14%105.99b
ABTUp 0.63%63.58b

Key Statistics

Forward P/E (1 yr):143.45
P/S (ttm):10.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.21
Quarterly EPS Est (Sep-16) :-0.04
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):7.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback